How to prepare a deal issues list from transaction documents for SAFE Financing Transactions

Prepare a company-side SAFE deal issues list by identifying the operative instruments, comparing them with the intended form, and connecting each material departure or evidence gap to a company decision. Review economics, conversion mechanics, side letters, authorization, and offering documentation together rather than treating each SAFE as an isolated contract. The deliverable is a source-linked decision table stating the affected investors, company exposure, preferred resolution, decision-maker, and evidence needed for closure. Separate verified departures from interpretive questions and missing documents so management knows what to negotiate and what to investigate.

When to use this workflow

Use this workflow when company counsel receives investor markups, inherits an incomplete SAFE financing file, or needs management decisions before accepting additional investments. It suits in-house teams and outside venture counsel preparing a focused negotiation agenda—not a full diligence report or closing checklist.

The scope is US SAFE financing, with Delaware corporate authorization addressed where applicable. Other formation jurisdictions, state securities requirements, negotiated governing law, and contractual restrictions need separate analysis. Rights depend on operative language and facts; the label “post-money SAFE” does not establish economics or participation rights. The process below is a professional workflow recommendation, not a statement that every listed check is legally mandatory.

What you need

Collect the proposed SAFE and identifiable form version, investor markups, executed instruments, amendments, side letters, and correspondence recording agreed terms. Obtain the current capitalization workbook, outstanding notes and other convertibles, option records and promises, charter, relevant approvals, and financing restrictions in debt or shareholder agreements.

Request the intended offering exemption, acceptance records, and investor commitment chronology. Separate signing, company acceptance, and funding evidence rather than treating them as interchangeable.

Identify who decides economics, approves legal departures, and retrieves missing records. Obtain management's intended cap, discount structure, fundraising amount, and investor-specific rights. These instructions establish the review baseline; they do not prove that the documents implement it.

Preserve superseded drafts but mark their status. Distinguish an unavailable side letter from a custodian's confirmed statement that none exists.

Use the template

Copy the SAFE Financing Transactions — Deal issues list into your working document or spreadsheet. Use one row per decision; combine investors only when their language and proposed treatment genuinely match.

Assign stable document IDs such as SAFE-01, SL-01, and CAP-01. Include clause or page references and, for workbooks, sheet names and cell ranges. Identify affected investors alongside the source.

Use the type field for a verified departure, missing evidence, interpretation question, or implementation issue. Explain priority through company exposure rather than an unexplained “high” label. The position field states the preferred outcome; the action field captures proposed wording or the investigation needed.

Name the decision-maker as well as the person preparing the response. Tie targets to a decision point, such as “before company acceptance.” Closure proof must identify the final document, approval, or verified record. Keep version and execution details in a linked document index if they would overcrowwd the table.

Step by step

1. Establish the operative set and comparison baseline

Number the documents and map each SAFE to amendments, side letters, approvals, and relevant correspondence. Separate executed agreements from proposed investments. An investor's latest markup is not necessarily the company's accepted version.

Identify the exact baseline form and company instructions before comparing text. If the original form cannot be established, compare against the proposed company terms and state that limitation. A difference from a familiar form is not automatically a defect.

Record conflicting versions and missing instruments as evidence issues. The template output should identify the affected investor, what cannot yet be concluded, and who must supply the record.

2. Reconcile economics before proposing language

Extract purchase amount, cap basis, Discount Rate, conversion-price selection, capitalization definitions, and option-pool treatment. Preserve the stated rate separately from the economic discount. Link calculations and assumptions to workbook cells.

The YC Post-Money SAFE User Guide explains that its post-money cap is post-SAFE money, not post-priced-round money. That explanation does not replace a negotiated instrument's capitalization definition.

For combined instruments, determine how cap and discount interact. CapCO2's filed Exhibit A, §2, illustrates selection of the price producing more shares. Its crowdfunding context does not establish customary economics or requirements for a Regulation D financing.

Record each mismatch with affected investors, model references, preferred treatment, and decision-maker. If the denominator remains uncertain, assign reconciliation rather than state definitive ownership percentages.

3. Map triggers to company obligations

Read conversion, liquidity, dissolution, priority, and termination provisions together. Compare relevant scenarios outside the issues list, then bring only consequential departures or uncertainties into the table.

Distinguish initial SAFE acceptance from later conversion. CapCO2's Exhibit A, §1(a), provides conversion at the initial Equity Financing closing and qualifies the investor's execution of financing documents with specified protections. Those are conversion-stage terms, not universal prerequisites to initial SAFE funding.

Check acquisition and dissolution separately, including insufficient proceeds. Identify the share class, payment formula, priority, required documents, and termination event under the actual instrument. Do not equate contractual cash-out language with guaranteed recovery.

Record the disputed trigger, resulting obligation, proposed clarification, and any conflict with another instrument. Check side-letter survival separately from SAFE termination.

4. Compare side letters across investors

Review participation, information, MFN, notice, amendment, and survival provisions alongside each SAFE. Identify rights requiring company action even where headline economics remain unchanged.

The YC guide describes its optional pro rata side letter as addressing participation in the financing where the SAFE converts. Broader negotiated wording needs separate analysis.

For an MFN provision, identify covered instruments, exclusions, notice requirements, and election mechanics before deciding whether a concession affects another investor. Compare actual clauses, not merely whether a side letter is present.

Record the investor set, operational consequence, and company position. Where breadth is intentional, seek an informed business decision rather than automatically recommend deletion. Link related rows when narrowing one investor's rights could require action under another instrument.

5. Separate authorization and offering issues from negotiation points

Review approvals against proposed terms and identify charter or contractual consents. For Delaware corporations, DGCL §157(a)–(b) addresses stock-acquisition rights or options and authorization terms, subject to the charter. Counsel must determine its application to the particular SAFE. Sections 152–153 address stock issuance and consideration, including the par-value floor; they do not alone establish sufficient authorized shares, valid preferred-stock terms, or all required approvals. (delcode.delaware.gov)

Confirm the exemption before assigning filing tasks. SEC Form D guidance identifies offerings under Rules 504 or 506 or Securities Act §4(a)(5) and requires filing within 15 days after the first investor becomes irrevocably contractually committed. A weekend or holiday deadline moves to the next business day. Do not automatically use the wire date; analyze state notices separately. (sec.gov)

Record evidence gaps, responsible counsel, and decision points. Classify each item as a legal prerequisite, express contractual condition, representation, covenant, or internal recommendation. Do not imply that filing Form D resolves the exemption analysis.

6. Turn findings into a prioritized company agenda

Order issues by the decisions they block. Put unresolved authority, material economic ambiguity, and inconsistent binding commitments ahead of cleanup that does not affect acceptance. Explain the ranking using transaction facts; there is no universal SAFE severity scale.

Each row should state a company position and, where useful, a fallback. Instead of “fix pro rata,” specify conversion-financing-only participation, relevant exclusions, and the endpoint sought. Identify who can approve a concession.

Keep routine collection tasks outside the executive agenda unless missing evidence prevents a material conclusion. Record proposed language or an investigation request, not merely a concern. The output should let management decide without reconstructing counsel's review.

7. Verify resolutions against final documents

Compare each revised SAFE and side letter against its issue row and related definitions. Correcting a headline cap does not resolve an inconsistent capitalization denominator.

Distinguish “company position approved,” “counterparty agreed,” “draft revised,” and “executed evidence verified.” An internal email is not sufficient closure evidence if the operative document still contains the disputed term.

Record final document IDs, clauses, approvals, and residual obligations. Where an issue remains open, identify the exact uncertainty and the person responsible for its disposition. Record business risk acceptance separately from counsel's determination of whether required legal or contractual steps remain outstanding.

Worked example

Fictional scenario. Juniper Harbor Robotics, Inc., a Delaware corporation, proposes a $1.8 million SAFE financing. Management intends a $12 million post-money cap, no discount, and participation rights limited to the conversion financing. All parties, amounts, records, and clause descriptions below are fictional.

Counsel receives Marlow Seed Partners' draft SAFE, Cedar Quay Ventures' draft SAFE and side letter, and a board consent. Marlow's draft includes an 85% Discount Rate and selects the lower conversion price. Cedar Quay's side letter covers every later equity issuance without a stated sunset. The consent approves an attached form, but its attachment is unavailable. No reviewed record establishes what the missing attachment contained.

The first row changes the discussion from form cleanup to economics. Under the fictional multiplication formula, an 85% rate produces a 15% price discount. Whether that branch produces more shares depends on the financing price and cap-derived price; exact dilution remains unquantified.

The second row identifies a broader concession without assuming the right's breadth was accidental. The third does not declare the financing unauthorized: it identifies an evidentiary limitation. Retrieval may resolve it, or counsel may determine that further approval is needed. These distinctions keep negotiation decisions separate from missing-source investigations.

Common mistakes

• Reviewing only the SAFE. Link amendments and side letters before concluding that investor terms match.
• Treating the cap as a dilution answer. Reconcile denominators, other convertibles, and option treatment before relying on calculations.
• Calling missing evidence a breach. State what is unavailable and assign verification before reaching a legal conclusion.
• Calling every task a closing condition. Identify its contractual or legal basis, or label it an internal recommendation.
• Closing issues on proposed wording. Verify final text, related definitions, approvals, and execution evidence appropriate to the issue.

Final quality check

• Every material finding has a verified source, stable document ID, and precise reference.
• Draft, executed, amended, and superseded records are distinguished.
• Economic conclusions identify assumptions and workbook references.
• Side-letter comparisons identify affected investors and actual triggers.
• Authorization and exemption questions have counsel-assigned owners.
• Proposed resolutions identify company positions and decision-makers.
• Closed rows identify final evidence; open rows have explicit ownership and disposition.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. In contract review, counsel can choose the company as the represented party in Word and provide deal-specific instructions. Findings quote clauses, rank severity, locate text, and identify missing language as not present. Lawyers can edit or insert suggestions as ordinary tracked changes in the signed-in Word user's name, or dismiss findings with reasons. Tabular review supports work across documents; due diligence classification can organize the review population and prioritize human review. Counsel retains judgment and maintains the issues list as a work product. Book a demo to discuss this workflow.

Frequently asked questions

Should every form departure become a deal issue?

No. Include departures affecting economics, rights, authority, operations, or a required decision. Keep inconsequential drafting cleanup in the redline unless it creates interpretive uncertainty.

Can cap-only and cap-and-discount SAFEs share one row?

Only for a genuinely common decision. Separate economic analysis where price selection or capitalization assumptions differ. Link rows when a concession may affect another investor's rights.

What if management accepts an unresolved risk?

Record the uncertainty, decision-maker, rationale, and remaining action. Business acceptance does not establish legal compliance or supply missing approvals. Counsel should distinguish negotiable exposure from requirements still needing resolution.

Is a missing side letter enough to stop acceptance?

Not automatically. Identify whether it could contain participation, MFN, or other rights affecting the financing. Assign retrieval and have counsel assess whether the specific uncertainty blocks acceptance.

Sources

• Delaware Code, Title 8, §§152–153 and 157: authorization and consideration provisions.
• SEC, Filing a Form D Notice: exemption-specific filing guidance.
• YC Post-Money SAFE User Guide, February 2023: instrument-developer explanation, not law.
• CapCO2 Solutions SEC-filed Exhibit A: illustrative crowdfunding SAFE wording, not an executed-term record, market-standard evidence, or SEC approval.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.